Who is sponsoring NCT03525977?

NCT03525977 is sponsored by Texas Tech University Health Sciences Center, El Paso.

What drugs are being tested in NCT03525977?

Interventions in NCT03525977: Fascia iliaca block arm.

What condition does NCT03525977 study?

NCT03525977 studies Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures).

Is NCT03525977 still recruiting?

NCT03525977 is currently completed. Last updated 28 May 2019.

Last reviewed 2019-05-28 · How we verify

NCT03525977

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Fascia Iliaca Block in Hip Fracture Patients

Completed NA Last updated 28 May 2019

What this trial tests

NA trial testing Fascia iliaca block arm in Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures) in 97 participants. Completed in 1 May 2019.

Timeline

20 February 2018

Primary endpoint
1 May 2019

1 May 2019

Quick facts

Lead sponsor	Texas Tech University Health Sciences Center, El Paso
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	97
Start date	20 February 2018
Primary completion	1 May 2019
Estimated completion	1 May 2019
Sites	1 location across United States

Drugs / interventions tested

Fascia iliaca block arm

Conditions studied

Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures) — all drugs for Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures) →

Sponsor

Texas Tech University Health Sciences Center, El Paso

Who can join

Adults 18 to 99, any sex, with Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a prospective randomized examining the impact of fascia iliaca block on perioperative pain control and post operative ambulation in patients with hip fractures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Peripheral nerve blocks for hip fractures in adults.
Guay J, Kopp S. · · 2020 · cited 78× · PMID 33238043 · DOI 10.1002/14651858.cd001159.pub3

Verify or expand the search:

Other Texas Tech University Health Sciences Center, El Paso trials

Trials by the same sponsor.

NCT06016465 — Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? · EARLY_PHASE1 · recruiting
NCT05303116 — Do EEG and Neurocognitive Assessments Correlate With COVID Brainfog Symptoms? · completed
NCT05174988 — Reducing Postoperative Bleeding After Hysterectomy Via Independent Closure of Vaginal Cuff Angles · NA · completed
NCT05077917 — Cromolyn Sodium for Treatment of COVID-19 Pneumonia · Phase 3 · terminated
NCT04786379 — Surgical Management of Knee Septic Arthritis · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03525977 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas Tech University Health Sciences Center, El Paso
Last refreshed: 28 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03525977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing